Vital Healthcare Property Trust logo

Vital announces interim FY2018 results

Full Year Results27 February 2018VHPReal Estate

INTERIM RESULTS
31 DECEMBER 2017

INVESTING IN AUSTRALASIA’S HEALTHCARE

INFRASTRUCTURE

27 FEBRUARY 2018

AGENDA
►Highlights

►Strategy

►Financials

►Portfolio

►Outlook

VITAL HEALTHCARE PROPERTY TRUST

2

HIGHLIGHTS

HIGHLIGHTS
Financial and portfolio performance delivering on strategy

4

Gross rental income

1

of $44.8m, +17.9%

Operating profit before tax

1

$30.4m, +3.5%

NDI

1

of $22.8m, -4.1%

AFFO

1

of $23.4m, -2.7%

NTA of $2.19, +6.5%

LVR of 36.8%, up from 29.3% at 30 June

2

nd

quarter distribution of 2.125 cents

Positive demographic trend due to ageing

population

65yr+ cohort utilises4x healthcare services

Healthcare is not a discretionary item

Public healthcare under funding pressure

Operators exploring partnership funding

model

Portfolio in great shape

Same property NOI growth of 3.5%

18.6 year WALE (+0.9 yrs), 99.3% occupancy

1.8% p.a. avg. lease expiry in next 10 years

NZ$144m development pipeline

Portfolio WACR firmed 17 bps to 5.85%

Completed five acquisitions for NZ$187m

Deliver strong, operational, financial and

portfolio results

Execution of acquisition & brownfield

pipelines, incremental value-add

Prudently manage balance sheet

Widen relationships with operating partners

Sustainable distribution and long-term value

creation

FinancialsStrategy & drivers

PortfolioOutlook

VITAL HEALTHCARE PROPERTY TRUST

(1) Comparative period results adjusted for $13.8m lease termination receipt in October 2016

-
50

100

150

200

250

300

350

400

Dec-07Dec-08Dec-09Dec-10Dec-11Dec-12Dec-13Dec-14Dec-15Dec-16Dec-17

Index rebased

to 100

10 Year CompoundAnnual Growth Rate

Vital 13.9%

vs.

S&P / NZX All Real Estate Index 8.0%

VHP

S&P/NZX

All Real

Estate

S&P/NZX

50Index

S&P/ASX

200 REIT

Index

VITAL’S PERFORMANCE

Strong execution driving material outperformance

5

VITAL HEALTHCARE PROPERTY TRUST

Source: CraigsInvestment Partners. Data as at 31 January 2018

STRATEGY

STRATEGIC FRAMEWORK
Building (blocks) to a healthy future

7

Stabilised

portfolio,

strong

underlying

thematics

Brownfield

developments

(capacity

expansion)

Acquisitions

Sustainable

long term

earnings &

value

creation

Management

Aligned / Stable / Experienced / Credible / Capable

Capital &

Treasury






Consistently strong performance delivering on overall strategy

VITAL HEALTHCARE PROPERTY TRUST

RECENT ACQUISITIONS
Diversified tenant covenant and extended overall lease term

8

VITAL HEALTHCARE PROPERTY TRUST

ACURITY HEALTHCARE PARTNERSHIP
9

VITAL HEALTHCARE PROPERTY TRUST

WAKEFIELD HOSPITAL, WELLINGTON
10

VITAL HEALTHCARE PROPERTY TRUST

Now

Proposed

BOWEN HOSPITAL, WELLINGTON
11

VITAL HEALTHCARE PROPERTY TRUST

ROYSTON HOSPITAL, HASTINGS
12

VITAL HEALTHCARE PROPERTY TRUST

DEVELOPMENT UPDATE
Development continues to enhance asset quality and portfolio value

13

VITAL HEALTHCARE PROPERTY TRUST

BudgetedSpendForecast

development costto datecompletion

Development(NZ$m)(NZ$m)date

Toronto Private (NSW)10.37.4Apr-18

North West Private (TAS)1.10.3May-18

Lingard Private (NSW)26.28.6Jun-18

Royston Hospital (Hastings, NZ)13.00.0Mid-2019

Wakefield Hospital (Wellington, NZ)82.00.0Mid-2021

Bowen Hospital (Wellington, NZ)11.50.0Mid-2019

Total144.116.3

* NZD/AUD at period end exchange rate of 0.9097

SECTOR DRIVERS AND TRENDS
Periodic regulatory reform, long term trends undeniable

VITAL HEALTHCARE PROPERTY TRUST -MEETING OF UNITHOLDERS

14

Regulatory

Public system

pressure

Relatively

insulated

reform relatively constant,

diversification

critical

private system

critical component

from macro financial,

economic and market

conditions

Economic & market influences

2x

80%~4x

>65 yeardemographic

forecast over

the next 40 years

>65 year demographic

have at least

one chronic disease

utilisation of

healthcare services

by >65 year demographic

Strong forecast demand, undeniable trends

PRIVATE HEALTH INSURANCE TRENDS
Strong PHI trends in NZ. Australian PHI growth stable but sector resilient

15

VITAL HEALTHCARE PROPERTY TRUST

10,000

10,200

10,400

10,600

10,800

11,000

11,200

11,400

11,600

11,800

12,000

1,300

1,310

1,320

1,330

1,340

1,350

1,360

1,370

1,380

1,390

1,400

Lives Covered (000's)

New Zealand (LHS)

Australia (RHS)

New Zealand PHI participation levels are 29%, Australia PHI participation levels are 46%

FINANCIALS

FINANCIAL PERFORMANCE
Core business activities drive positive operating results

17

VITAL HEALTHCARE PROPERTY TRUST

Gross rent growth driven by acquisition, organic growth and development activities

Total expenses higher due to management fees on increased assets under management. Incentive fee of

$5.8m accrued as compared to $3.5m accrued in the same period last year and $13m for the full year 2017.

Vital’spayoutratio for the half year remains conservative at 81%

Actual

Normalised

Change

Change

1H18

1H17*

$m

%

Gross rental income

44.8

38.0

6.8

17.9%

Net rental income

43.2

37.0

6.2

16.6%

Total expenses

12.8

7.7

5.1

67.2%

Operating profit before tax

30.4

29.3

1.0

3.5%

Gross distributable income

25.7

26.1

-0.4

-1.6%

Current tax - New Zealand & Australia

2.9

2.3

0.6

23.6%

Effective tax rate

11.3%

9.0%

Net distributable income

22.8

23.8

-1.0

-4.1%

Net distributable income per unit (earned) (cpu)

5.26c

5.73c

-0.5c

-8.0%

Net distributable income payout ratio

81%

74%

Units on issue (weighted average, millions)

432.8

414.9

Weighted average NZD/AUD exchange rate

0.92

0.95

*adjusted for $13.8m lease termination receipt received in October 2016 and associated tax implications

(in millions of $NZ, except per unit amounts)

DISTRIBUTABLE INCOME
Conservative payout ratio at both NDI and AFFO level

18

VITAL HEALTHCARE PROPERTY TRUST

Actual

Normalised

Change

Change

1H18

1H17*

$m

%

Profit before income tax

61.1

41.2

19.9

48.3%

Revaluation (gains)/losses

-42.8

-13.1

-29.7

226.5%

Unrealised FX (gains)/losses

1.6

2.6

-0.9

-35.8%

Derivative fair value adjustment (gains)/losses

-0.1

-8.1

8.0

-98.6%

Managers incentive fee

5.8

3.5

2.3

66.3%

Gross distributable income

25.7

26.1

-0.4

-1.6%

Current tax

2.9

2.3

0.6

23.6%

Net distributable income

22.8

23.8

-1.0

-4.1%

Amortisation of deferred financing charges

0.2

0.2

0.0

11.8%

Amortisation of leasing costs & tenant inducements

0.5

0.3

0.1

45.8%

Funds from operations (FFO)

23.5

24.3

-0.8

-3.3%

Actual capex & leasing from continuing operations

-0.1

-0.3

0.2

-59.6%

Adjusted funds from operations (AFFO)

23.4

24.0

-0.6

-2.7%

AFFO (cpu)

5.40c

5.78c

-0.4c

-6.7%

AFFO payout ratio

79%

73%

*adjusted for $13.8m lease termination receipt received in October 2016 and associated tax implications

(in millions of $NZ, except per unit amounts)

NET OPERATING INCOME
Acquisitions and developments were key drivers of core rent growth

19

VITAL HEALTHCARE PROPERTY TRUST

Same property NOI growth was 3.5% for the 6 month period, over the prior year.

BALANCE SHEET
Strong balance sheet supports execution of strategy

20

VITAL HEALTHCARE PROPERTY TRUST

Portfolio value growth reflects acquisition activity, foreign exchange and revaluation gains

Cost of debt reflective of additional NZ$191m of facility drawdowns at market rates

Gearing at normal levels following partial pay down of facilities in July 2016

Acquisition capacity of approximately NZ$200m

Actual

Actual

change

change

1H18

FY17

$

%

Investment properties

1,670.8

1,376.2

294.6

21.4%

Weighted average cap rate

5.85%

6.03%

-17 bps

Total assets

1,687.4

1,392.2

295.2

21.2%

Bank debt

613.6

401.9

211.7

52.7%

Weighted average cost of debt

1

4.09%

4.34%

-25 bps

LVR

36.8%

29.3%

753 bps

Unitholder funds

952.3

879.8

72.5

8.2%

Units on issue (m)

435.4

428.6

6.8

1.6%

Net Tangible Assets

2.19

2.05

0.13

6.5%

Period end NZD/AUD exchange rate

0.91

0.95

(1) Includes line and margin

(in millions of $NZ, except per unit amounts)

INVESTMENT PROPERTY
Acquisitions and FX key drivers of property uplift over the first six months

21

VITAL HEALTHCARE PROPERTY TRUST

1,376.4

187.4

10.5

42.8

54.0 1,671.0

0

200

400

600

800

1,000

1,200

1,400

1,600

1,800

FY17AcquisitionsCapital

additions

Change in

fair value

FX1H18

NZ $millions

NZ

portfolio

in NZ$

Australian

portfolio

in A$

Australian

portfolio

translated into

NZ$

A $1,057.7m

NZ$265.7m

A $1,159.8m

NZ$395.8m

NTA MOVEMENT
NTA uplift reflective of foreign exchange and revaluation gains

22

VITAL HEALTHCARE PROPERTY TRUST

PORTFOLIO

STRONG GEOGRAPHIC DIVERSIFICATION
42 investment properties comprising ~2,550 beds and ~95 operating theatres.

24

VITAL HEALTHCARE PROPERTY TRUST

Indicates number of

assets in each state

Geographic split (%)

76/24

Australia/New Zealand

by value

PORTFOLIO COMPOSITION
New partnership with Acurityincreases weighting to Acute Surgical in New Zealand

25

VITAL HEALTHCARE PROPERTY TRUST

SECTOR DIVERSIFICATIONGEOGRAPHIC DIVERSIFICATION

NSW

33%

NZ

24%

VIC

19%

QLD

13%

SA

4%

TAS

1%

WA

6%

Acute Surgical

58%

Medical office

buildings

12%

Mental health

14%

Rehabilitation

10%

Aged care

4%

Strategic

2%

CORE PORTFOLIO METRICS
Resilient metrics underpin defensive qualities, driving financial performance

26

Consistent occupancy levels

at almost 100% capacity

underpins sustainable

portfolio performance

Long WALE reflects a range

of factors including

proactive management,

partners willing to commit

to quality well-located

facilities, new lease

extensionsand acquisitions

High level of structured

reviews ensures steady

income growth over the long

term, regardless of

economic cycles

VITAL HEALTHCARE PROPERTY TRUST

15.1

17.1

18.4

17.7

18.6

0

4

8

12

16

20

2014

2015

2016

2017

H1 2018

Years

WALE

99.3%

99.4%

99.6%

99.1%

99.3%

95%

96%

97%

98%

99%

100%

2014

2015

2016

2017

H1 2018

Percentage of income

Occupancy

Total income subject to

structured rent reviews

85.4%

72.6%

92.2%

82.9%

85.8%

0%

20%

40%

60%

80%

100%

2014201520162017H1 2018

Percentage of income

LEASE EXPIRY PROFILE
Low risk expiry profile = sustainable, predictable and defensive cash flows

27

VITAL HEALTHCARE PROPERTY TRUST

0%

2%

4%

6%

8%

10%

12%

18

19

20

21

22

23

24

25

26

27

Percentage of portfolio (by income)

Total expiry

Largest single rent expiring

1.8% p.a.

average lease

expiry over the

next 10 years

80% of income expiries

after 2028

INTERIM REVALUATION
Strong interim revaluations validate strategy

28

VITAL HEALTHCARE PROPERTY TRUST

Revaluation summary

Revaluation gain of $42.8m, +2.9% above book value

Values supported by external independent desktop reviews

Majority of gain from Australian portfolio

Australian WACR firmed ~16 bps to 5.85%, New Zealand ~14 bps to 5.86%

Portfolio WACR firmed ~17 bps to 5.85%

Drivers

Firming cap rates for institutional quality healthcare assets

Increased interest in social infrastructure assets from global investment managers

Low interest rate environment, unique and attractive lease terms

OUTLOOK

OUTLOOK
Investing in Australasia’s Healthcare Infrastructure

30

Deliver strong operational, financial and portfolio results -driven by scale and

diversification

Execution of acquisition and development pipelines, continuation of incremental

value-add opportunities

Acquire strategic sites to support operator growth

Prudently deploy balance sheet to appropriate opportunities

Widen and strengthen relationships with operatingpartners to support our strategy

Focus on sustainable distributions and long term-value creation

VITAL HEALTHCARE PROPERTY TRUST

DISCLAIMER
This presentation has been prepared by NorthWestHealthcare Properties

Management Limited (the "Manager“, formerly Vital Healthcare

Management Limited) as manager of the Vital Healthcare Property Trust

(the "Trust"). The details in this presentation provide general information

only. It is not intended as investment or financial advice and must not be

relied on as such. You should obtain independent professional advice prior

to making any decision relating to your investment or financial needs.

The provision of this presentation does not constitute an offer, invitation or

recommendation to subscribe for or purchase units in the Trust.

Past performance is no indication of future performance.

No money is currently being sought, and no applications for units will be

accepted, or money received, unless the unitholders have received an

investment statement and a registered prospectus from the Trust.

27 February 2018

31

VITAL HEALTHCARE PROPERTY TRUST

GLOSSARY
32

AFFO

Adjusted Funds From Operations is an alternate measure used for assessing distributable income. Essentially

adjusts NPAT for all non-cash items (i.e. NDI) then makes adjustments for items such as maintenance capex

and lease incentives paid

Cap rate

Capitalisation rate. Generally calculated as net operating income / current market value of investment

property

CPI

Consumer Price Index. An index that measures the change in the cost of a 'basket' of basic goods and

services, showing how the cost of living changes over time. The most widely accepted indicator of inflation

FEC

Foreign Exchange Contract. Generally considered as a contracted commitment to buy/sell a specified amount

of a foreign currency on a fixed date at a fixed rate of exchange

FX

An abbreviation for ‘foreign exchange’ used where there is a transaction in a currency other than the local

currency

LVR

Loan to Value Ratio. Is the ratio of a loan to the value of an asset purchased or total assets. The term is

commonly applied by looking at the level of Borrowings (or debt) versus the Total Assets, or Borrowings

versus the Investment Properties

NDINet Distributable Income. Calculated as Gross Distributable Income less Current tax charges

NTA

Net Tangible Assets. The total assets of the Trust less total liabilities. NTA is normally divided by the number

of units on issue and expressed as an amount per unit

WACR

Weighted Average market CapitalisationRate. The market cap rate for each property weighted by property

value

WALE

Weighted Average Lease term to Expiry.The weighted average lease term remaining to expire across a

portfolio, sometimes also referred to as WALT

VITAL HEALTHCARE PROPERTY TRUST

---

vhpt.co.nz
27 February 2018


Vital announces interim FY2018 results

Vital Healthcare Property Trust (Vital) today released its interim results for the six

months ended 31 December 2017 and confirmed a second quarter cash distribution

of 2.125 cents per unit will be paid to unitholders on 29 March 2018.

Highlights

 Portfolio lease term increased to 18.6 years (from 17.7 years at 30 June 2017), while retaining high

occupancy levels at 99.3%

 Same property NOI increased 3.5% over the prior year period

 Net Distributable Income of $22.8m or 5.26c per unit

 AFFO per unit of 5.40c, generating a sector leading payout ratio of approximately 79%

 Cap rate firmed to 5.85% (from 6.03% at 30 June 2017), generating an interim gain of $42.8m

 NTA per unit of $2.19, up 7% from 30 June 2017

 Finance costs declined 57bps to 4.09%, gearing at 36.8%

 Acquisition of Acurity New Zealand Hospital portfolio, Eden Rehabilitation Hospital and The Hills Clinic

in Australia for NZ$187m

 Development pipeline (6 projects) of approximately NZ$144m over the next four years

 Management integration further strengthening market leading Australasian healthcare platform


David Carr, Chief Executive of Vital’s Manager, said, “Aligning with our core strategy, many of Vital’s recent

acquisitions have been ‘off-market’ sale and leaseback investments. These opportunities enable Vital to work

closely with our partners and be thoughtful about lease terms in order to deliver exceptional long term outcomes.

Many of these investments include attractive future development opportunities where we continue to support our

partners with long-term capital, backed by undeniable demographic and healthcare demand trends.

Notwithstanding a busy period looking at new opportunities the team continues to ensure that the core portfolio

remains in great shape. Over the six months we extended our market leading portfolio lease term from 17.7 years

to 18.6 years and continued to maintain portfolio occupancy over 99%.

Investment trends in healthcare real estate, with long-term leases and positive demographic demand trends,

remain competitive, leading to further yield compression in our sector. Accordingly, we continue to see positive

revaluations which has been a consistent driver of NTA growth over recent years, under-pinning unit price

performance.

We retain a positive outlook and we are excited about a range of asset management initiatives and potential

opportunities over the remainder of 2018,” said Mr Carr.

Management integration further strengthens market leading Australasian platform

In January 2018, Vital’s management company announced the integration of its New Zealand and Australian

management platforms. Effective today, Vital’s manager will transition to its new name, NorthWest Healthcare

Properties Management Limited from Vital Healthcare Management Limited. Vital Healthcare Property Trust’s

name will not change, nor will its NZX ticker symbol “VHP”.

David Carr and Stuart Harrison will continue as Chief Executive Officer and Chief Financial Officer, respectively.

There is no change to Vital’s well defined strategy, remaining absolutely focused on healthcare real estate

investment with a continued focus on distribution sustainability and long-term value creation.


vhpt.co.nz

Vital unitholders will benefit from a larger team working on their behalf, in both New Zealand and Australia,

strengthening and broadening key relationships as Australasia’s pre-eminent healthcare management platform.

Interim valuations and portfolio activity

In order to assess whether any valuation change has occurred for the half year to 31 December 2017, the

incumbent independent valuers from 30 June 2017 were commissioned to provide external desktop reviews. As a

result, Vital recorded an increase of $42.8m in the fair value of its portfolio to $1.67bn, or 2.9% over carrying book

value. The increase is over and above acquisitions and development expenditure incurred in the period.

Vital’s WACR for the six months to 31 December 2017 firmed approximately 17 bps to 5.85%. The Australian

portfolio reported a 16 bps firming in capitalisation rate to 5.85% and the New Zealand portfolio firmed 14 bps to

5.86%. The valuation uplift was primarily driven by firmer capitalisation rates, but also supported by incremental

increases in income as a result of rent reviews over the period.

Vital’s WALE increased to 18.6 years (from 17.7 years) primarily reflecting the recent acquisition of the Acurity

portfolio with initial lease terms of 30 years. The long WALE and consistently high occupancy levels of above 99%

are portfolio traits that underpin Vital’s sustainable distribution and reflect the depth of established long-term

relationships with key partners.

A total of 31 rent reviews (approximately 22% of total income) were completed to 31 December 2017, resulting in

rent growth of 1.1%. With around 45% of Vital’s total income remaining subject to review to 30 June 2018, we

expect these reviews will contribute to forecast income growth over the period approximately in line with inflation.

With a relatively benign lease expiry profile at the start of FY18 representing 1.7% of total income (22 leases),

approximately half of these renewals or expiries are now completed, with a 100% retention rate. We look to

resolve the remaining expiries over the next six months with a high expectation of renewal and we also continue to

proactively focus on expiries beyond 2018.

Financial performance

Gross rental income grew 17.9% during the period after adjusting for a one-off lease termination receipt of $13.8m

relating to two Gold Coast properties in the prior year. After property expenses, net income grew 16.6%.

This strong operating result was driven by same-property income growth of 3.5% and over NZ$410m of

acquisitions and approximately NZ$40m of developments over the last 24 months.

Finance expense of $10.5m was up 55% from the prior year owing to higher overall debt levels during the last 12

months. This reflects significant acquisition and development activity following the pay down of bank facilities on

the back of the July 2016 capital raise.

Other expenses increased to $12.8m primarily the result of an accrual provision for a manager incentive fee of

$5.8m ($3.5m in 1H17) along with base management fees increasing to $5.6m ($3.7m in 1H17) due to the higher

asset base over the previous period. The incentive fee provision is calculated in accordance with the Trust Deed

and based on the average increase in the value of the Trust’s assets over book value for the last three years, and

does not crystallise until the end of the financial year following completion of the 30 June 2018 year-end

independent asset valuations.

Net distributable income for the period was $22.8m equating to 5.26 cpu. Adjusting for income related to a one-off

lease termination and rental reversion on re-leasing at two Gold Coast properties, net distributable income per unit

for the period increased 3.5% from the prior year. AFFO, which adjusts for maintenance capital expenditure and

lease incentives, was broadly in line with net distributable income on a per unit basis.

For the six months to 31 December 2017, Vital’s AFFO payout ratio reflected a prudent and sustainable 79%.

Treasury & capital management

Vital’s loan-to-value ratio (LVR) was 36.8% at 31 December 2017, up from 24.4% the same time last year. It

remains well below bank and Trust Deed covenants of 50%. Accordingly, the Trust maintains an appropriate level

of flexibility to finance announced development commitments over the next four years.

Partially offsetting the increased finance expense due to higher gearing was a 57bps decrease in Vital’s weighted

average cost of debt to 4.09% (including bank line and margin fees) compared to the prior year.

At year end Vital had a hedged interest rate position of 51.9% with a 5.76 year average duration.

Acquisitions

Vital acquired five properties in the first half of the year for a total cost of NZ$187m.

In July 2017, Vital closed on the acquisition of The Hills Clinic in Kellyville, NSW, 40km north-west of the Sydney

CBD for A$30.3m. The Hills is a two-storied purpose-built mental health hospital leased to Healthe Care,

Australia’s third largest corporate private hospital operator and pan-Asian healthcare services group, on a 30-year

lease.


About Vital Healthcare Property Trust


Vital Healthcare Property Trust (NZX: VHP) is Australasia’s largest listed investor in healthcare real estate. Tenants include hospital operators and

healthcare practitioners who deliver a wide range of medical and healthcare related services. The Manager of Vital Healthcare Property Trust is

NorthWest Healthcare Properties Management Limited (formerly Vital Healthcare Management Limited).


.vhpt.co.nz

In December 2017, Vital acquired Eden Rehabilitation Hospital in Cooroy, Queensland for A$23.8m. Eden is a

private rehabilitation hospital leased to Healthe Care Australia for 20 years, with future brownfield potential.

Also in December 2017, Vital received OIO approval to acquire the previously announced Wakefield and Bowen

Hospitals in Wellington and acquired a third asset from Acurity Health Group, Royston Hospital in Hastings, for a

combined NZ$122m. Vital has also committed to fund up to NZ$106.5m of brownfield development at the three

hospitals over the next four years.

Development activity

In the first half of the year, Vital completed brownfield developments at Sportsmed Consulting in Adelaide,

Maitland Private Hospital in NSW and the Palm Beach Currumbin Clinic in Queensland representing value-add

investments of approximately A$20m over the life of these projects.

Three further projects, totalling approximately A$34m remain in various stages of development. The projects will

facilitate expansion of healthcare services including additional operating theatres, ward expansions and new

consulting suites to meet increased demand for services. These three projects are forecast for completion

between April and June 2018, with approximately A$21m in costs to complete.

The longer term brownfield development programme, which totals approximately NZ$144m including the

aforementioned projects under construction and planned works in the Acurity portfolio, remains a core part of

Vital’s scale and diversification strategy. It will continue to underpin earnings sustainability, improve asset quality

and enhance long-term value.

Distribution

The Board confirmed that investors will receive a second quarter distribution of 2.125 cents per unit with 0.1543

cpu of imputation credits attached. The record date is 15 March 2018 and payment will be made on 29 March

2018. Vital’s Distribution Reinvestment Plan remains available to investors for this distribution with a 1.0%

discount being applied when determining the strike price.

The Board has also reconfirmed its full year guidance for a cash distribution of 8.5 cents per unit.

Outlook

Mr Carr said “With a solid foundation and a defensive and resilient portfolio position, we look forward to the

continued execution of our disciplined scale and diversification strategy.

Irrespective of periodic political or regulatory interference in otherwise entrenched healthcare systems in New

Zealand and Australia, we continue to see strong demographic, aging and technological trends driving demand for

healthcare services – delivered from quality healthcare infrastructure. Vital is at the forefront of this structural

growth opportunity with the most experienced healthcare real estate management team in Australasia and the

reputation as a preferred healthcare real estate capital partner, we are well placed for the future”.

Vital’s management team will present these results via a live webcast from 2pm NZ time today. Please refer to our

market release dated 13 February 2018 for details or click here.


– ENDS -



ENQUIRIES

David Carr, Chief Executive Officer

NorthWest Healthcare Properties Management Ltd, Telephone 09 973 7301, Email dcarr@vhpt.co.nz


Stuart Harrison, Chief Financial Officer

NorthWest Healthcare Properties Management Ltd, Telephone 09 973 7302, Email sharrison@vhpt.co.nz


Jason Kepecs, Manager, Investor Relations

NorthWest Healthcare Properties Management Ltd, Telephone 09 973 7303, Email jkepecs@vhpt.co.nz

---

Reporting Period6 months to 31 December 2017
Previous Reporting Period6 months to 31 December 2016

Amount

NZ$000s

Percentage

change

Revenue from ordinary activities

-15.1%

Profit (loss) from ordinary activities after tax

attributable to security holder

16.2%

Net profit (loss) attributable to security holders

52,88016.2%

Interim/Final DividendAmount per

security

Imputed amount

per security

NZ$0.02125NZ$0.001543

Record Date

Dividend Payment Date

Comments:Refer

announcement

43,153

52,880

VITAL HEALTHCARE PROPERTY TRUST

Results for announcement to the market

15 March 2018

29 March 2018

VITAL HEALTHCARE PROPERTY TRUST FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2017
1FINANCIAL STATEMENTS

FINANCIAL

STATEMENTS

FOR THE PERIOD

ENDED

31 DECEMBER

2017

VITAL HEALTHCARE PROPERTY TRUST FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2017
FIN-1FINANCIAL STATEMENTS

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the period ended 31 December 2017

Note

Unaudited

6 months

Dec-17

$000s

Unaudited

6 months

Dec-16

$000s

Gross property income from rentals44,75251,775

Gross property income from expense recoveries5,1833,353

Property expenses(6,782)(4,315)

Net property income343,15350,813

Other income/(expenses)(12,794)(7,650)

Finance income5771

Finance expense(10,540)(6,817)

Operating Profit19,87636,417

Other gains/(losses)

Revaluation gain/(loss) on investment property642,77413,100

Fair value gain/(loss) on foreign exchange derivatives(284)(701)

Fair value gain/(loss) on interest rate derivatives1168,080

Unrealised gain/(loss) on foreign exchange(1,366)(1,869)

41,24018,610

Profit before income tax61,11655,027

Taxation expense4(8,236)(9,503)

Profit for the period attributable to unitholders of the Trust52,88045,524

Other comprehensive income

Items that may be reclassified subsequently to profit and loss:

Movement in foreign currency translation reserve34,020(4,547)

Realised foreign exchange gains/(losses) on hedges1,63410,129

Current taxation (expense)/credit(458)(2,836)

Unrealised foreign exchange gains/(losses) on hedges(3,656)(8,505)

Deferred taxation (expense)/credit1,0242,381

Fair value gain/(loss) on net investment hedges(4,445)715

Deferred taxation (expense)/credit1,244(200)

Total other comprehensive income/(loss) after tax29,363(2,863)

Total comprehensive income after tax82,24342,661

Earnings per unit

Basic and diluted earnings per unit (cents)512.2210.97

The notes on pages FIN-5 to FIN-14 form part of and are to be read in conjunction with these financial statements.

VITAL HEALTHCARE PROPERTY TRUST FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2017
FIN-2FINANCIAL STATEMENTS

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

As at 31 December 2017

Note

Unaudited

Dec-17

$000s

Audited

Jun-17

$000s

Non-current assets

Investment properties61,670,8461,376,243

Derivative financial instruments71,0751,499

Other non-current assets326327

Total non-current assets1,672,2471,378,069

Current assets

Cash and cash equivalents10,4533,352

Trade and other receivables1,368367

Other current assets2,2427,886

Derivative financial instruments71,0992,554

Total current assets15,16214,159

Total assets1,687,4091,392,228

Unitholders' funds

Units on issue8553,824538,469

Reserves11,557(11,295)

Retained earnings386,933352,647

Total unitholders' funds952,314879,821

Non-current liabilities

Borrowings9613,588401,879

Income in advance1,1361,541

Derivative financial instruments711,54312,142

Deferred tax77,88071,719

Total non-current liabilities704,147487,281

Current liabilities

Trade and other payables9,70211,537

Income in advance3,1142,407

Derivative financial instruments72,64097

Taxation payable15,49211,085

Total current liabilities30,94825,126

Total liabilities735,095512,407

Total unitholders' funds and liabilities1,687,4091,392,228

For and on behalf of the Manager, Vital Healthcare Management Limited

G. Horsley, ChairmanC. Higgins, Director

27 February 2018

The notes on pages FIN-5 to FIN-14 form part of and are to be read in conjunction with these financial statements.

VITAL HEALTHCARE PROPERTY TRUST FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2017
FIN-3FINANCIAL STATEMENTS

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

For the period ended 31 December 2017

Units on issue

$000s

Retained

earnings

$000s

Translation

of foreign

operations

$000s

Foreign

exchange

hedges

$000s

Share based

payments

$000s

Total

unitholders'

funds

$000s

For the six months ended

31 December 2016 (Unaudited)

Balance at the start of the period369,220171,617(81,530)58,0956,317523,719

Changes in unitholders' funds166,056---(6,317)159,739

Manager's incentive fee----3,4903,490

Profit for the period-45,524---45,524

Distributions to unitholders-(18,363)---(18,363)

Other comprehensive income for

the period

Movement in foreign currency

translation reserve--(4,547)--(4,547)

Realised foreign exchange gains

on hedges---7,293-7,293

Unrealised foreign exchange gains/

(losses) on hedges---(6,124)-(6,124)

Fair value gains on net investment

hedges---515-515

Balance at the end of the period535,276198,778(86,077)59,7793,490711,246

For the six months ended

31 December 2017 (Unaudited)

Balance at the start of the period538,469352,647(83,713)60,10412,314879,821

Changes in unitholders' funds15,355---(12,314)3,041

Manager's incentive fee----5,8035,803

Profit for the period-52,880---52,880

Distributions to unitholders-(18,594)---(18,594)

Other comprehensive income for

the period

Movement in foreign currency

translation reserve--34,020--34,020

Realised foreign exchange gains on

hedges---1,176-1,176

Unrealised foreign exchange gains/

(losses) on hedges---(2,632)-(2,632)

Fair value losses on net investment

hedges---(3,201)-(3,201)

Balance at the end of the period553,824386,933(49,693)55,4475,803952,314

The notes on pages FIN-5 to FIN-14 form part of and are to be read in conjunction with these financial statements.

VITAL HEALTHCARE PROPERTY TRUST FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2017
FIN-4FINANCIAL STATEMENTS

CONSOLIDATED STATEMENT OF CASH FLOWS

For the period ended 31 December 2017

Note

Unaudited

6 months

Dec-17

$000s

Unaudited

6 months

Dec-16

$000s

Cash flows from operating activities

Property income44,94255,923

Recovery of property expenses4,3083,213

Interest received4364

Property expenses(6,167)(6,298)

Management and trustee fees(5,575)(3,910)

Interest paid(9,620)(6,566)

Tax (paid)/refund755(2,839)

Other trust expenses(1,014)(3,452)

Net cash provided by/(used in) operating activities27,67236,135

Cash flows from investing activities

Receipts from foreign exchange derivatives1,63411,087

Capital additions on investment properties(9,801)(9,921)

Purchase of properties(182,510)(103,649)

Prepaid acquistion costs(1,003)(51)

Tenant incentives(2,314)(1,088)

Payments for foreign exchange derivatives(171)-

Net cash provided by/(used in) investing activities(194,165)(103,622)

Cash flows from financing activities

Debt drawdown189,16886,504

Issue of units (net of issue costs)-156,525

Repayment of debt-(169,356)

Costs associated with Distribution Reinvestment Plan(14)(12)

Distributions paid to unitholders(15,553)(15,643)

Net cash from/(used in) financing activities173,60158,018

Net increase/(decrease) in cash and cash equivalents7,108(9,469)

Effect of exchange rate changes on cash and cash equivalents(7)14

Cash and cash equivalents at the beginning of the period3,35212,980

Cash and cash equivalents at the end of the period10,4533,525

The notes on pages FIN-5 to FIN-14 form part of and are to be read in conjunction with these financial statements.

VITAL HEALTHCARE PROPERTY TRUST FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2017
FIN-5FINANCIAL STATEMENTS

NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the six months ended 31 December 2017

1 GENERAL INFORMATION

Vital Healthcare Property Trust ("VHP" or the "Trust") is a unit trust established under the Unit Trusts Act 1960 by

a Trust Deed dated 11 February 1994 as subsequently amended and replaced, domiciled in New Zealand. The

Trust is managed by Vital Healthcare Management Limited (the Manager). The Manager is a registered managed

investment scheme manager under the Financial Markets Conduct Act.

The condensed consolidated interim financial statements of VHP for the period ended 31 December 2017

comprise VHP and its subsidiaries (together referred to as the Group). VHP is listed on the New Zealand Stock

Exchange (NZX) and is a FMC reporting entity for the purpose of the Financial Markets Conduct Act 2013.

The Trust's principal activity is the investment in health sector related properties.

The condensed consolidated interim financial statements are presented in New Zealand Dollars ($) which is the

Trust's functional and presentation currency. All information has been rounded to the nearest thousand dollars

($000), unless stated otherwise.

These condensed consolidated interim financial statements were approved by the Board of Directors of the

Manager on 27 February 2018.

2 BASIS OF PREPARATION

Statement of compliance

These condensed consolidated interim financial statements have been prepared in accordance with Generally

Accepted Accounting Practice in New Zealand (NZ GAAP), NZ IAS 34 and IAS 34 Interim Financial Reporting. The

accounting policies have been consistently applied, when compared to those used in the 2017 Annual Report. The

2017 Annual Report complies with New Zealand equivalents to International Financial Reporting Standards (NZ

IFRS) and other applicable Financial Reporting Standards issued and effective at the time of preparing those

statements.

Basis of measurement

The condensed consolidated interim financial statements have been prepared on the historical cost basis except

for derivative financial instruments and investment properties which are measured at fair value.

Use of estimates and judgements

The preparation of financial statements in conformity with NZ IFRS requires the use of certain critical accounting

estimates and judgements that affect the application of policies and reported amount of assets and liabilities,

income and expenses. The areas involving a higher degree of judgement or complexity, or areas where

assumptions and estimates are significant to the financial statements are as follows:


Note 4 - taxation


Note 6 - valuation of investment property

Amendments to NZ IFRS

All standards and amendments effective in the current period have been adopted and have no impact on these

condensed consolidated interim financial statements.

VITAL HEALTHCARE PROPERTY TRUST FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2017
FIN-6FINANCIAL STATEMENTS

NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (CONT.)

3 SEGMENT INFORMATION

The principal business activity of the Trust and its subsidiaries is to invest in Health Sector related properties. NZ

IFRS 8 requires operating segments to be identified on the basis of internal reports about components of the

Group that are regularly reviewed by the Board of Directors of the Manager, which is the chief operating decision

maker in order to allocate resources to the segments and to assess their performance.

The information reported to the Group's chief operating decision maker is based on primarily one industry sector,

investing in Health Sector related properties. The Group operates in both Australia and New Zealand.

The following is an analysis of the Group's revenue and results from continuing operations by reportable segment.

Australia

$000s

New Zealand

$000s

Total

$000s

Segment profit for the period ended

31 December 2017 (Unaudited):

Net property income34,4378,71643,153

Other expense(5,004)(7,790)(12,794)

Net finance expense(5,548)(4,935)(10,483)

23,885(4,009)19,876

Fair value gain/(loss) on interest rate derivatives-116116

Revaluation gains on investment properties37,8074,96742,774

Other foreign exchange gains/(losses)-(1,650)(1,650)

Total segment profit before income tax61,692(576)61,116

Taxation (expense)--(8,236)

Profit for the period--52,880

Segment profit for the period ended

31 December 2016 (Unaudited):

Net property income42,9337,88050,813

Other expense(3,497)(4,153)(7,650)

Net finance expense(2,809)(3,937)(6,746)

36,627(210)36,417

Fair value gain/(loss) on interest rate derivatives-8,0808,080

Revaluation gains on investment properties10,3992,70113,100

Other foreign exchange gains/(losses)(3)(2,567)(2,570)

Total segment profit before income tax47,0238,00455,027

Taxation (expense)--(9,503)

Profit for the period--45,524

VITAL HEALTHCARE PROPERTY TRUST FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2017
FIN-7FINANCIAL STATEMENTS

NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (CONT.)

3 SEGMENT INFORMATION (continued)

Net property income consists of revenue generated from external tenants less property operating expenditure.

The Group has two tenants with over 10% of gross property income from rentals totalling $25.4m, all in Australia

(31 December 2016: two tenants totalling $33.7m).

Included in net property income for the six months ended 31 December 2016 is a lease termination receipt of

$13.8m.

Segment profit represents the profit earned by each segment including allocation of identifiable administration

costs, finance costs, revaluation gains/(losses) on investment properties, and gains/(losses) on disposal of

investment properties. This is the measure reported to the chief operating decision maker for the purposes of

resource allocation and assessment of segment performance.

Australia

$000s

New Zealand

$000s

Total

$000s

Segment assets at 31 December 2017 (Unaudited):

Investment properties1,275,012395,8341,670,846

Other non-current assets2931,1081,401

Current assets7,0758,08715,162

Consolidated assets1,282,380405,0291,687,409

Segment assets at 30 June 2017 (Audited):

Investment properties1,110,530265,7131,376,243

Other non-current assets2861,5401,826

Current assets4,8139,34614,159

Consolidated assets1,115,629276,5991,392,228

Segment liabilities at 31 December 2017 (Unaudited):

Borrowings476,303137,285613,588

Other liabilities90,04231,465121,507

Consolidated liabilities566,345168,750735,095

Segment liabilities at 30 June 2017 (Audited):

Borrowings270,855131,024401,879

Other liabilities77,90732,621110,528

Consolidated liabilities348,762163,645512,407

For the purposes of monitoring segment performance and allocating resources between segments:


All assets are allocated to reportable segments


All liabilities are allocated to reportable segments

VITAL HEALTHCARE PROPERTY TRUST FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2017
FIN-8FINANCIAL STATEMENTS

NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (CONT.)

4 TAXATION

Unaudited

6 months

Dec-17

$000s

Unaudited

6 months

Dec-16

$000s

Profit before tax for the period61,11655,027

Taxation expense - 28% on profit before income tax(17,113)(15,408)

Effect of different tax rates in foreign jurisdictions8,0204,560

Tax exempt income1,796736

Foreign tax credits1,7632,918

Tax charges on overseas investments(4,279)(2,668)

Over/(under) provided in prior periods1,26375

Other adjustments314284

Taxation (expense)(8,236)(9,503)

The taxation (expense) is made up as follows:

Current taxation(2,890)(4,411)

Deferred taxation(5,346)(5,092)

Total taxation (expense)(8,236)(9,503)

VITAL HEALTHCARE PROPERTY TRUST FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2017
FIN-9FINANCIAL STATEMENTS

NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (CONT.)

5 EARNINGS PER UNIT

Basic and diluted earnings per unit is calculated by dividing the profit attributable to unitholders of the Trust by the

weighted average number of ordinary units on issue during the period.

Unaudited

Dec-17

Unaudited

Dec-16

Profit attributable to unitholders of the Trust ($000s)52,88045,524

Weighted average number of units on issue (000's of units)432,849414,852

Basic and diluted earnings per unit (cents)12.2210.97


Unaudited

Dec-17

$000's

Unaudited

Dec-16

$000's

Distributable income

Profit before income tax61,11655,027

Revaluation (gains)(42,774)(13,100)

Unrealised foreign exchange (gain)/loss1,3661,869

Unrealised foreign exchange (gain)/loss derivatives284701

Unrealised interest rate (gain)/loss derivatives(116)(8,080)

Manager's incentive fee5,8033,490

Profit used in calculating gross distributable income25,67939,907

Current tax charge(2,890)(4,411)

Profit used in calculating net distributable income22,78935,496

Gross distributable income (cpu) *5.939.62

Net distributable income (cpu) *5.268.56

* Based on weighted average number of units on issue.

VITAL HEALTHCARE PROPERTY TRUST FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2017
FIN-10FINANCIAL STATEMENTS

NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (CONT.)

6 INVESTMENT PROPERTIES

Unaudited

Dec-17

$000s

Audited

Jun-17

$000s

Carrying value of investment property at the beginning of the period1,376,243951,879

Acquisition of properties187,384223,562

Capitalised costs10,23331,637

Capitalised interest costs402302

Net capitalised incentives(167)2,048

Foreign exchange translation difference53,977(1,734)

Change in fair value42,774168,549

Carrying value of investment property at the end of the period1,670,8461,376,243

Carrying value of investment property includes:

Fair value of investment properties1,668,2561,372,587

Income in advance2,5903,656

Carrying value of investment property at the end of the period1,670,8461,376,243

Investment Properties Valuation

The Group's policy is for investment property to be measured at fair value for which the Group completes property

valuations at least annually by independent registered valuers. All investment property was valued by independent

registered valuers as at 30 June 2017. The fair value of investment property as at 31 December 2017 was

determined by the Manager, using market data provided by independent valuers and based on independent

valuation advice. This follows recent comparable transactional evidence of market property sale transactions and

a review of leasing activity undertaken in the period.

The Group holds the freehold to all properties except the car parks at the rear of Ascot Hospital and Ascot

Central. The total value of leasehold property at 31 December 2017 was $3.1m (30 June 2017: $3.2m)

representing 0.2% of the total investment property portfolio (30 June 2017: 0.2%). The weighted average lease

length of leasehold property at 31 December 2017 was 1.3 years (30 June 2017: 1.8 years).

Acquisition of properties

During the period, the Group acquired five healthcare properties. Three properties are located in New Zealand, two

in Wellington and one in Hastings.Two properties are in Australia, one in Cooroy, Queensland, and one in Kellyville,

New South Wales . The purchase prices included Australian stamp duty and other transaction costs.

VITAL HEALTHCARE PROPERTY TRUST FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2017
FIN-11FINANCIAL STATEMENTS

NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (CONT.)

7 DERIVATIVE FINANCIAL INSTRUMENTS

Hedge Accounting

The Group is exposed to foreign exchange risk on its net investment in its Australian functional currency

subsidiaries and hedges this risk using Australian denominated borrowings and foreign exchange derivatives.

The Group has designated Australian denominated borrowings and foreign exchange derivatives as hedges of a net

investment in a foreign operation (net investment hedge). The Group prospectively and retrospectively tests the

hedges for effectiveness on a semi-annual basis. The portion of the foreign exchange differences arising on the

hedging instruments determined to be an effective hedge is recognised in other comprehensive income. Any

ineffective portion is recognised in profit or loss.

The face value of hedging instruments designated in net investment hedges is:

Unaudited

Dec-17

$000s

Audited

Jun-17

$000s

Borrowings98,93494,488

Forward exchange contracts (nominal amount)219,853104,987

Interest rate swaps

Interest rate swaps are measured using a valuation model based on the present value of estimated future cash

flows and discounted based on the applicable yield curves derived from observable market interest rates. The

Group has determined the interest rate swaps are Level 2 fair value measurements. The fair value of interest rates

swaps is a liability of $10,624,836.

Foreign exchange derivatives

Foreign exchange derivatives are measured using a valuation model based on the applicable forward price curves

derived from observable forward prices. The Group has determined the foreign exchange derivatives are Level 2

fair value measurements. The fair value of foreign exchange derivatives is a liability of $1,384,237.

There have been no reclassifications of fair value instruments between levels in the period ended 31 December

2017 and 30 June 2017.

Derivatives are all carried at fair value on the Statement of Financial Position. The carrying amounts of all other

financial instruments approximate their fair value.

Unaudited

Dec-17

$000s

Audited

Jun-17

$000s

Nominal value of foreign exchange contracts - AUD100,00050,000

Nominal value of foreign exchange options - AUD100,00050,000

VITAL HEALTHCARE PROPERTY TRUST FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2017
FIN-12FINANCIAL STATEMENTS

NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (CONT.)

8 UNITS ON ISSUE

Unaudited

Dec-17

$000s

Audited

Jun-17

$000s

Balance at the beginning of the period538,469369,220

Issue of units under Distribution Reinvestment Plan3,0735,928

Issue of units under Rights Issue-159,932

Issue of units to satisfy Manager's incentive fee12,3146,317

Issue costs of units(32)(2,928)

15,355169,249

Balance at the end of the period553,824538,469

Unaudited

Dec-17

000s

Audited

Jun-17

000s

Reconciliation of number of units

Balance at the beginning of the period428,562345,998

Issue of units under the Distribution Reinvestment Plan1,4062,795

Units issued under Rights Issue-76,891

Units issued to satisfy Manager's incentive fee5,4402,878

Balance at the end of the period435,408428,562

The number of units on issue at 31 December 2017 was 435,408,454 (30 June 2017: 428,562,486). The units have

no par value and are fully paid. Fully paid ordinary units carry one vote per unit and carry the right to distributions.

On 23 August 2017, 5,440,157 units were issued against the 2017 Manager's incentive fee of $12,314,339 (30 June

2017: $6,316,611).

Capital risk management

The Group is subject to imposed capital requirements arising from the Trust Deed, which requires the total

borrowings do not exceed 50% of the gross value of the Trust Fund.

The Group's banking covenants require that the aggregate principal amount of the loan outstanding does not

exceed 50%, (30 June 2017: 50%) of the fair market value of property at all times calculated to the Australian

dollar equivalent. All banking covenants have been met during the period.

The Group manages its capital to ensure that entities in the Group will be able to continue as a going concern

while maximising the return to stakeholders through the optimisation of the debt and equity balance. The Group's

policies in respect of capital management and allocation are reviewed regularly by the Board of Directors of the

Manager. There have been no material changes in the Group's overall capital risk management strategy during the

period.

VITAL HEALTHCARE PROPERTY TRUST FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2017
FIN-13FINANCIAL STATEMENTS

NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (CONT.)

9 BORROWINGS

Unaudited

Dec-17

$000s

Audited

Jun-17

$000s

AUD denominated loans614,628402,649

Borrowing costs(1,040)(770)

Total borrowings613,588401,879

The Group has a syndicated revolving multi-currency facility with ANZ Bank New Zealand Limited, Australia and

New Zealand Banking Group Limited and Bank of New Zealand. The multi-currency facilities of A$600.0m and NZ

$20.0m are split between: Tranche A: A$125.0m and Tranche B: A$100.0m which are due to expire on 31 March

2019; and Tranche C: A$100.0m, Tranche D: A$100.0m and NZ Dollar Facility: NZ$20.0m which are due to expire

on 31 October 2020; and Tranche E: A$175m which is due to expire on 20 November 2021.

The effective interest rate on the borrowings as at 31 December 2017 was 4.09% per annum (30 June 2017:

4.34%).

Borrowings are secured by a Security Trust Deed dated 1 April 2003 and as amended and restated on

29 November 2016. The Security Provider comprises T.E.A. Custodians Limited in its capacity as nominee of the

VHP Trustee as supervisor of the Trust and the Trust's subsidiaries. Pursuant to the Deed, a security interest has

been granted of first ranking mortgages over the respective investment properties by a General Security Deed over

the assets and undertakings of Vital Healthcare Property Limited and fixed and floating charges over the assets

and undertakings of Vital Healthcare Australian Property Pty Limited in its capacity as trustee for Vital Healthcare

Australian Property Trust and Vital Healthcare Investment Trust.

10 COMMITMENTS

Unaudited

Dec-17

$000s

Audited

Jun-17

$000s

Capital Commitments

The Group was party to contracts to purchase or construct property for the

following amounts:36,77078,234

Lease Commitments

The property rental income expected to be earned by the Group from its investment property, all of which is

leased out under operating leases, is set out in the table below:

Not later than one year

95,95480,901

Later than one year and not later than five years357,609293,850

Later than five years1,355,9031,059,951

1,809,4661,434,702

As a condition of listing on the New Zealand Stock Exchange (NZSX), NZSX requires all issuers to provide a bank

bond to NZSX under NZSX/DX Listing Rule 2.6.2. The bank bond required by the Trust for listing on the NZSX is

$50,000.

VITAL HEALTHCARE PROPERTY TRUST FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 DECEMBER 2017
FIN-14FINANCIAL STATEMENTS

NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (CONT.)

11 CONTINGENCIES

There were no contingencies as at 31 December 2017 (30 June 2017: nil).

12 SUBSEQUENT EVENTS

On 26 February 2018 the manager changed its name from Vital Healthcare Management Limited, to NorthWest

Healthcare Properties Management Limited.

On 27 February 2018 a gross distribution of 2.125 cents per unit was announced by the Trust. The record date for

the distribution is 15 March 2018 and a payment is scheduled to unitholders on 29 March 2018. There will be

0.1543 cents per unit of imputation credits attached to the distribution.

13 RELATED PARTY TRANSACTIONS

The Manager

The Trust is managed by Vital Healthcare Management Limited (the "Manager"). The Manager is a wholly owned

subsidiary of NWI Healthcare Properties LP. The Manager is related to the Trust and its subsidiaries as the

manager of the Trust.

Remuneration of the Manager

The Trust paid management fees to the Manager. The calculation of management fees and incentive fees is

stipulated in the Trust Deed. Management fees have been charged at 0.75% of the monthly average of the gross

value of the assets of the Trust for the quarter ended on the last day of that month. Incentive fees are payable

when there is an average annual increase in the gross value of the assets of the Trust Fund over the relevant

financial year and the two preceding financial years. The incentive fee calculation may give rise to an excess or

deficit to be applied in the calculation of future incentive fees. The incentive fee is 10% of the amount of the

increase with payment being made by way of subscribing for new units. The management and incentive fees shall

not exceed an amount equal to 1.75% per annum of the gross value of the Trust.

Transactions with related parties include:

Unaudited

Dec-17

$000s

Unaudited

Dec-16

$000s

Total fees incurred

Management fees5,5893,743

Manager's incentive fees5,8033,490

Expenses charged by Vital Healthcare Management Limited92218

Expenses charged by Vital Healthcare Australian Property Pty Limited1,1791,290

12,6638,741

Properties owned by the Trust have been managed by Vital Healthcare Management Limited, a subsidiary of NWI

Healthcare Properties LP. Property management fees charged are either included in property expenses or

capitalised. The amount paid to Vital Healthcare Management Limited for reimbursement of expenses was

$92,430 (31 December 2016: $218,108). The amount not recovered from tenants was nil (31 December 2016: nil).

15
INDEPENDENT REVIEW REPORT

TO THE UNITHOLDERS OF VITAL HEALTHCARE PROPERTY TRUST

We have reviewed the condensed consolidated interim financial statements of Vital Healthcare Property Trust and its

subsidiaries (together referred to as ‘the Trust’) which comprise the consolidated statement of financial position as at 31

December 2017, and the consolidated statement of comprehensive income, consolidated statement of changes in equity

and consolidated statement of cash flows for the six month period ended on that date, and a summary of significant

accounting policies and other explanatory information on pages FIN-1 to FIN-14.

This report is made solely to the Trust’s unitholders, as a body. Our review has been undertaken so that we might state to

the Trust’s unitholders those matters we are required to state to them in a review report and for no other purpose. To the

fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Trust’s unitholders as

a body, for our engagement, for this report, or for the opinions we have formed.

Manager’s Responsibilities

The Board of Directors of the Manager are responsible for the preparation and fair presentation of the condensed

consolidated interim financial statements, in accordance with NZ IAS 34 Interim Financial Reporting and IAS 34 Interim

Financial Reporting and for such internal control as the Board of Directors of the Manager determine is necessary to

enable the preparation and fair presentation of the condensed consolidated interim financial statements that are free

from material misstatement, whether due to fraud or error.

Our Responsibilities

Our responsibility is to express a conclusion on the condensed consolidated interim financial statements based on our

review. We conducted our review in accordance with NZ SRE 2410 Review of Financial Statements Performed by the

Independent Auditor of the Entity (‘NZ SRE 2410’). NZ SRE 2410 requires us to conclude whether anything has come to

our attention that causes us to believe that the condensed consolidated interim financial statements, taken as a whole,

are not prepared, in all material respects, in accordance with NZ IAS 34 Interim Financial Reporting and IAS 34 Interim

Financial Reporting. As the auditor of Vital Healthcare Property Trust, NZ SRE 2410 requires that we comply with the

ethical requirements relevant to the audit of the annual financial statements.

A review of the condensed consolidated interim financial statements in accordance with NZ SRE 2410 is a limited

assurance engagement. The auditor performs procedures, primarily consisting of making enquiries, primarily of persons

responsible for financial and accounting matters, and applying analytical and other review procedures.

The procedures performed in a review are substantially less than those performed in an audit conducted in accordance

with International Standards on Auditing (New Zealand). Accordingly we do not express an audit opinion on those

financial statements.

Other than in our capacity as auditor, we have no relationship with or interests in Vital Healthcare Property Trust or its

subsidiaries or the Manager.

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the condensed consolidated interim

financial statements of the Trust do not present fairly, in all material respects, the financial position of the Group as at 31

December 2017 and its financial performance and cash flows for the six month period ended on that date in accordance

with NZ IAS 34 Interim Financial Reporting and IAS 34 Interim Financial Reporting.

Chartered Accountants

AUCKLAND, NEW ZEALAND

27 February 2018

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.